Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Fierce Pharma
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain
October 10, 2022 -
PR Newswire
AppliedVR Wins Q3 2022 Comparably Awards-recognized for Happiest Employees, Best Company Compensation, Best Work-Life Balance and Best Perks & Benefits
October 10, 2022 -
PR Newswire
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
October 9, 2022 -
PR Newswire
OSF HealthCare Partnering with US HealthVest on new behavioral health hospital
October 6, 2022 -
PR Newswire
New Mental Health Company Led by Consumer Brand Industry Veterans to Revolutionize Mental Health Care Delivery for Seniors
September 28, 2022 -
Business Wire
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 28, 2022 -
PR Newswire
Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry
September 27, 2022 -
MedCity News
Prime Medicine spells out IPO plans for ‘word processor’ of gene editing
September 23, 2022 -
PR Newswire
NodThera Announces Positive Phase 1 Study Readouts for the NLRP3 Inflammasome Inhibitors NT-0796 and NT-0249
September 21, 2022 -
GlobeNewswire
Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection
September 19, 2022 -
GlobeNewswire
RIGImmune Announces Acquisition of Antiviral Company Subintro and Concurrent Financing by F-Prime Capital
September 15, 2022 -
MobiHealthNews
Provider search firm Kyruus buys patient engagement company Epion Health
September 15, 2022 -
Fierce Biotech
AviadoBio selected by Fierce Biotech as a ‘Fierce 15’ 2022 winner
September 12, 2022 -
Business Wire
Artemis Health and Zerigo Health Announce Partnership to Help Employers and Health Plans Better Evaluate and Manage Chronic Autoimmune Skin Conditions
September 8, 2022 -
PR Newswire
Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
September 7, 2022 -
PR Newswire
Avidity Biosciences Enrolls Patients in the MARINA™ Open-Label Extension Study
August 2, 2022 -
Business Wire
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
August 1, 2022 -
PR Newswire
Centivo names Jim Foreman Chairman of the Board of Directors
July 27, 2022 -
PR Newswire
Vitalxchange Joins Buoy Health’s Marketplace to Provide Special Needs and Disability Parenting Solutions
July 26, 2022 -
PR Newswire
AppliedVR Announces Results from a Clinical Trial Follow-up Study Finding RelieVRx Delivers Durable Effects Six Months After Completing Treatment
July 21, 2022 -
Business Wire
Morgan Health Announces New Investment in Centivo
July 19, 2022 -
PR Newswire
Eleos Expands Leadership Team with R&D, Finance Hires
July 19, 2022 -
GlobeNewswire
Protenus Recognized as a Top Healthcare Compliance Provider
July 12, 2022 -
Business Wire
WelbeHealth Becomes First Program of All-Inclusive Care for the Elderly (PACE) Provider to Convert to Public Benefit Company Status
June 29, 2022 -
Business Wire
Kyruus Announces Paul Merrild as Company’s First President
June 29, 2022 -
GlobeNewswire
Protenus is Top-Performing Solution in KLAS Drug Diversion Monitoring 2022 Report
June 24, 2022 -
GlobeNewswire
Equip Publishes Study Showing Virtual Treatment is Highly Effective for Eating Disorders as Company Expands to 50 States
June 22, 2022 -
Forbes
Sondermind -The Company Redesigning Behavioral Health For Patients And Therapists
June 21, 2022 -
Economics Times
Immuneel Therapeutics raises $15 million in funding
June 21, 2022 -
PR Newswire
Insilico Medicine appoints Dr. Feng Ren as co-CEO
June 16, 2022 -
GlobeNewswire
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
June 16, 2022 -
Endpoints
As their first clinical data test looms, global AI player Insilico bumps up a GSK vet to co-CEO in charge of development
June 16, 2022 -
Fierce Biotech
Has Denali found a way to correct gene mutations linked to Parkinson’s? Possibly, but questions remain
June 14, 2022 -
PR Newswire
PROXIMIE RAISES $80 MILLION IN SERIES C FUNDING TO ACCELERATE PRODUCT EXPANSION OF FULL-SERVICE CONNECTED SURGICAL PLATFORM
June 14, 2022 -
Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
June 9, 2022 -
Endpoints
Big names, big backers: David Baker joins OrbiMed, F-Prime, Khosla and others as protein-ligand biotech launches
June 9, 2022 -
Business Insider
Exclusive: Medical AI startup Owkin just secured $80 million as it gears up to enhance drug trials with the pharmaceutical giant Bristol Myers Squibb
June 8, 2022 -
GlobeNewswire
Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
June 7, 2022 -
Business Wire
Ontrak Health and Eleos Announce AI Integration Partnership to Support Care for Ontrak Members
June 7, 2022 -
PR Newswire
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
June 6, 2022 -
PR Newswire
MediKarma Selects 1upHealth as its Interoperability Partner to Help Patients Acquire Their Medical Records from Hospital EMRs
June 6, 2022 -
PR Newswire
Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
June 5, 2022 -
Fierce Pharma
Sana Biotechnology ditches California manufacturing plans in bid to save $100M
June 2, 2022 -
Fierce Pharma
Sana Biotechnology ditches California manufacturing plans in bid to save $100M
June 2, 2022 -
PR Newswire
1upHealth Selected by NCQA As Partner in Digital Quality Solutions Pilot
June 1, 2022 -
Axios
SpectrumAi, an LA startup centered on autism, raised $9M in seed funding
June 1, 2022 -
PR Newswire
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
May 24, 2022 -
GlobeNewswire
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
May 24, 2022 -
Business Wire
WellAir Brings Clean Air Technology to Brandywine Realty Trust Properties
May 18, 2022 -
GlobeNewswire
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
May 17, 2022 -
Business Wire
AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain
May 17, 2022 -
GlobeNewswire
Coherus BioSciences Appoints Dr. Jill O’Donnell-Tormey to its Board of Directors
May 12, 2022 -
GlobeNewswire
Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
May 12, 2022 -
PR Newswire
NodThera Announces Clinical Progress for Lead NLRP3 Inflammasome Inhibitors and Candidate Selection of Novel Brain-Penetrant Compound
May 10, 2022 -
GlobeNewswire
Singular Genomics Announces Formation of Scientific Advisory Board
May 10, 2022 -
GlobeNewswire
Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results
May 10, 2022 -
Fierce Biotech
Rallybio wades into Sanofi storeroom for $3M rare disease deal
May 10, 2022 -
Boston Globe
Invetx raises $60.5 million to make long-lasting antibody therapies for cats and dogs
May 10, 2022 -
GlobeNewswire
Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid Nanoparticle Delivery Data in Non-Human Primates at TIDES USA 2022
May 9, 2022 -
MedCity News
How cell & gene therapy startups can warm up to investors in this “biotech nuclear winter”
May 9, 2022 -
PR Newswire
Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers
May 5, 2022 -
GlobeNewswire
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
May 2, 2022 -
Fierce Healthcare
AppliedVR taps Komodo Health to prove out its VR therapeutic for chronic pain
April 29, 2022 -
Business Wire
WellAir Announces Kari Dixon as President and Chief Executive Officer
April 29, 2022 -
Globenewswire
Wellframe Addresses the Caregiver Crises Through an Expanded Program Aimed to Assist 250,000 Members by 2025
April 28, 2022 -
GlobeNewswire
Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
April 28, 2022 -
MIT Technology Review
These fast, cheap tests could help us coexist with covid
April 27, 2022 -
PR Newswire
1upHealth Announces SQL on FHIR® to Easily Ask Hard Questions of Healthcare FHIR® Data and Make Timely Real-World Decisions
April 27, 2022 -
Fierce Biotech
Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
April 27, 2022 -
PR Newswire
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
April 25, 2022 -
MedCity News
MedCity Pivot Podcast: A conversation with Buoy Health’s chief medical officer
April 21, 2022 -
Business Wire
Artemis Health Launches New Solution to Improve Evaluation and Optimization of Point Solutions
April 21, 2022 -
PR Newswire
Eleos Health and Zero Suicide Institute Join Forces to Incorporate Best Practices for Suicide Prevention Into Eleos’ Platform
April 19, 2022 -
Business Wire
Turnstone Biologics Announces Executive Leadership Appointments
April 19, 2022 -
Globenewswire
Protenus Granted New Patent ‘Methods and Systems for Analyzing Accessing of Drug Dispensing Systems’
April 19, 2022 -
PR Newswire
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
April 19, 2022 -
PR Newswire
Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment
April 13, 2022 -
PR Newswire
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
April 13, 2022 -
GlobeNewswire
Orchard Therapeutics Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy
April 11, 2022 -
PR Newswire
PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
April 7, 2022 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
April 6, 2022 -
PR Newswire
Doceree Closes $11 Million Series A Funding Round Led by F-Prime Capital
April 6, 2022 -
PR Newswire
Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data
April 5, 2022 -
Business Wire
Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market
April 5, 2022 -
PR Newswire
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
April 5, 2022 -
PR Newswire
HealthTap Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
April 5, 2022 -
Business Wire
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
April 4, 2022 -
Business Wire
Ivenix to be Acquired by Fresenius Kabi
March 31, 2022 -
PR Newswire
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
March 29, 2022 -
PR Newswire
AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care
March 28, 2022
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.